Cervical Cancer
Conditions
Keywords
Radical Hysterectomy, Laparoscopic Surgery, Early-Stage Cervical Cancer, Minimally Invasive Surgery
Brief summary
The study aims to compare laparoscopic-assisted radical hysterectomy with open radical hysterectomy in women with early-stage cervical cancer. A total of 60 patients diagnosed with FIGO stage IA1, IA2, and IB1 cervical cancer were enrolled and randomly assigned into two equal groups: laparoscopic surgery and open surgery. All patients underwent total hysterectomy, bilateral adnexectomy, and pelvic lymph node dissection. Perioperative outcomes were evaluated, including operative time, blood loss, complications, and hospital stay, as well as long-term oncological outcomes such as recurrence, recurrence-free survival, and overall survival. Patients were followed for up to three years postoperatively. The findings of this study aim to assess the safety, feasibility, and clinical effectiveness of laparoscopic-assisted surgery compared with the conventional open approach in the management of early-stage cervical cancer.
Detailed description
Cervical cancer remains one of the leading causes of cancer-related morbidity and mortality among women worldwide. Radical hysterectomy is the standard surgical treatment for early-stage cervical cancer. Traditionally, this procedure has been performed through an open abdominal approach; however, minimally invasive techniques, including laparoscopic-assisted radical hysterectomy, have gained increasing attention due to their potential advantages in reducing surgical trauma and improving perioperative recovery. This study was conducted to compare the clinical and oncological outcomes of laparoscopic-assisted radical hysterectomy versus open radical hysterectomy in patients with early-stage cervical cancer. A total of 60 patients diagnosed with FIGO stage IA1, IA2, and IB1 cervical cancer were included. Participants were admitted to Zagazig University Hospitals between March 2021 and January 2024. Eligible patients were randomly assigned into two groups: a laparoscopic surgery group and an open surgery group. All patients underwent total hysterectomy, bilateral adnexectomy, and pelvic lymph node dissection. In the laparoscopic group, vaginal stump closure was performed using an endoscopic stapler, whereas in the open group, closure was performed using conventional surgical techniques. Primary outcomes included perioperative parameters such as operative time, intraoperative blood loss, blood transfusion, complications, hospital stay, and time to removal of urinary catheter and drainage tube. Secondary outcomes included long-term oncological outcomes such as recurrence rate, recurrence-free survival, and overall survival. Patients were followed for up to three years postoperatively. The study aimed to determine whether laparoscopic-assisted radical hysterectomy provides comparable safety and oncological outcomes to open surgery while offering potential advantages in perioperative recovery. This study was registered retrospectively, as patient enrollment had been completed prior to trial registration, in accordance with journal requirements and to ensure transparency in reporting.
Interventions
In this procedure, a minimally invasive laparoscopic-assisted radical hysterectomy is performed, including dissection of the pelvic lymph nodes and closure of the vaginal stump with an endoscopic stapler.
A standard open abdominal radical hysterectomy includes dissection of the pelvic lymph nodes and the closure of the vaginal stump.
Sponsors
Study design
Masking description
This study is an open-label study due to the nature of the surgical interventions, where neither participants nor investigators were blinded
Intervention model description
The study Participants were assigned into two parallel groups to undergo either laparoscopic-assisted radical hysterectomy or open radical hysterectomy. The study compares perioperative and long-term oncological outcomes between the two surgical approaches.
Eligibility
Inclusion criteria
* FIGO stage IA1, IA2, IB1 * patients with a tumor size \< 2 cm by MRI or pathological assessment after conization * tumours with histopathological subtypes: squamous cell carcinoma, adenocarcinoma and adeno-squamous carcinoma ( * patients with adequate; hematopoietic, renal and liver functions: * patients with BMI \< 35 ( * patients with age range 38 - 65 years old.
Exclusion criteria
* patients with mental, heart, bladder, liver, or kidney illness * patients who had received pre-operative chemotherapy or radiotherapy pregnant patients * patients with incomplete data or lost follow-up * patients with radiological evidence of invasion of the outer 1/3 of the cervical stroma or the lower uterine segment.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Operative Time | Intraoperative period (day of surgery) | The surgery duration will be measured in minutes from skin incision to closure. |
| Intraoperative Blood Loss volume | Intraoperative period | Assessment of volume of intraoperative blood loss (mL): Estimated blood loss volume measured in millilitres during surgery. |
| Length of Hospital Stay | Up to 30 days post-surgery | Duration of hospital stay measured in days from surgery to discharge |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Recurrence Rate | Up to 3 years postoperatively | Assessment of cancer recurrence following surgical intervention during the follow-up period. |
Countries
Egypt
Contacts
Zagazig University